FDA Inspection 957265 — Innovative Blood Resources, Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, Division Of New York Blood Center, Inc. on Feb 3, 2016 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 3, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln, NE (United States)